Literature DB >> 28600334

How I use laboratory monitoring of antiplatelet therapy.

Alan D Michelson1, Deepak L Bhatt2.   

Abstract

Antiplatelet therapy is of proven benefit in coronary artery disease and a number of other clinical settings. This article reviews platelet function, molecular targets of antiplatelet agents, and clinical indications for antiplatelet therapy before focusing on a frequent question to hematologists about the 2 most commonly used antiplatelet therapies: Could the patient be aspirin "resistant" or clopidogrel "resistant"? If so, should results of a platelet function test be used to guide the dose or type of antiplatelet therapy? Whether such guided therapy is of clinical benefit to patients has been a source of controversy. The present article reviews this subject in the context of 2 prototypical clinical cases. Available evidence does not support the use of laboratory tests to guide the dose of aspirin or clopidogrel in patients with so-called aspirin or clopidogrel "resistance."
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28600334     DOI: 10.1182/blood-2017-03-742338

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Heparin-Induced Thrombocytopenia and Cardiac Surgery: Can We Do It All With Cangrelor?

Authors:  Kenichi A Tanaka; Reney Henderson; Brittney Williams
Journal:  A A Pract       Date:  2019-11-01

2.  Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study.

Authors:  Xiao-Fei Gao; Shu Lu; Zhen Ge; Guang-Feng Zuo; Zhi-Mei Wang; Feng Wang; Xiang-Quan Kong; Da-Yang Chai; Shao-Liang Chen; Jun-Jie Zhang
Journal:  BMC Cardiovasc Disord       Date:  2018-05-24       Impact factor: 2.298

Review 3.  The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD).

Authors:  Mohammed Ahmed Akkaif; Nur Aizati Athirah Daud; Abubakar Sha'aban; Mei Li Ng; Muhamad Ali Sk Abdul Kader; Dzul Azri Mohamed Noor; Baharudin Ibrahim
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

Review 4.  Antiplatelet Therapy for Atherothrombotic Disease in 2022-From Population to Patient-Centered Approaches.

Authors:  Georges Jourdi; Anne Godier; Marie Lordkipanidzé; Guillaume Marquis-Gravel; Pascale Gaussem
Journal:  Front Cardiovasc Med       Date:  2022-01-28

Review 5.  Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review.

Authors:  Adel Alhazzani; Poongothai Venkatachalapathy; Sruthi Padhilahouse; Mohan Sellappan; Murali Munisamy; Mangaiyarkarasi Sekaran; Amit Kumar
Journal:  Front Neurol       Date:  2021-06-10       Impact factor: 4.003

Review 6.  Potentiation of thrombus instability: a contributory mechanism to the effectiveness of antithrombotic medications.

Authors:  Diana A Gorog
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

7.  Management of a decompensated acute-on-chronic intracranial venous sinus thrombosis.

Authors:  Carmen Serna Candel; Victoria Hellstern; Tania Beitlich; Marta Aguilar Pérez; Hansjörg Bäzner; Hans Henkes
Journal:  Ther Adv Neurol Disord       Date:  2019-12-24       Impact factor: 6.570

Review 8.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy.

Authors:  Bhawani Yasassri Alvitigala; Lallindra Viranjan Gooneratne; Godwin Roger Constantine; Rajapaksha Arachchige Namal Kumarasiri Wijesinghe; Liyanage Dona Ashanthi Menuka Arawwawala
Journal:  Pharmacol Res Perspect       Date:  2020-12

Review 9.  Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease.

Authors:  Eman Abdelghani; Clifford L Cua; Jean Giver; Vilmarie Rodriguez
Journal:  Cardiol Ther       Date:  2021-06-29

Review 10.  Cyclic nucleotide-dependent inhibitory signaling interweaves with activating pathways to determine platelet responses.

Authors:  Zoltan Nagy; Albert Smolenski
Journal:  Res Pract Thromb Haemost       Date:  2018-06-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.